The Only Monthly Membership With a Positive ROI!
España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
The Only Monthly Membership With a Positive ROI!
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Gain Therapeutics
GANX
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$1.05
0.01
0.96%
At Close: -
$1.02
-0.03
-2.86%
After Hours: Jul 26, 12:59 AM EDT
15 minutes delayed
Get Report
Comment
Gain Therapeutics (GANX) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Gain Therapeutics (NASDAQ:GANX) Stock
Gain Therapeutics Stock (NASDAQ: GANX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, July 11, 2024
HC Wainwright & Co. Reiterates Buy on Gain Th...
Benzinga Newsdesk
Tuesday, July 09, 2024
Gain Therapeutics Advances Parkinson's Therap...
Benzinga Newsdesk
Thursday, July 04, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Tuesday, July 02, 2024
HC Wainwright & Co. Maintains Buy on Gain The...
Benzinga Newsdesk
Thursday, June 27, 2024
Gain Therapeutics Appoints Gene Mack As Inter...
Benzinga Newsdesk
Gain Therapeutics Presents GT-02287 Data At F...
Benzinga Newsdesk
Friday, June 14, 2024
S&P 500 Edges Lower; RH Shares Plunge After Q1 Results
Avi Kapoor
Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Gold Gains 1%; US Consumer Sentiment Falls In June
Avi Kapoor
Dow Tumbles Over 200 Points; Adobe Earnings Top Views
Avi Kapoor
Why Adobe Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Gain Therapeutics shares are trading lower af...
Benzinga Newsdesk
Reported Earlier, Gain Therapeutics Prices $1...
Benzinga Newsdesk
Thursday, June 13, 2024
Gain Therapeutics Plans To Offer And Sell Sha...
Benzinga Newsdesk
Friday, May 31, 2024
HC Wainwright & Co. Reiterates Buy on Gain Th...
Benzinga Newsdesk
Thursday, May 30, 2024
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights
Gain Therapeutics Says Late-Breaking Abstract...
Benzinga Newsdesk
Tuesday, May 28, 2024
HC Wainwright & Co. Reiterates Buy on Gain Th...
Benzinga Newsdesk
Wednesday, May 15, 2024
HC Wainwright & Co. Reiterates Buy on Gain Th...
Benzinga Newsdesk
Tuesday, May 14, 2024
Gain Therapeutics' Q1 Cash, Cash Equivalent A...
Benzinga Newsdesk
Thursday, April 25, 2024
HC Wainwright & Co. Reiterates Buy on Gain Th...
Benzinga Newsdesk
Wednesday, April 24, 2024
Gain Therapeutics Reports Results From Single...
Benzinga Newsdesk
Tuesday, April 23, 2024
Oppenheimer Maintains Outperform on Gain Ther...
Benzinga Newsdesk
Monday, April 08, 2024
Gain Therapeutics Appoints Gene Mack As CFO
Benzinga Newsdesk
Tuesday, April 02, 2024
Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying
Avi Kapoor
Monday, April 01, 2024
HC Wainwright & Co. Reiterates Buy on Gain Th...
Benzinga Newsdesk
Wednesday, March 27, 2024
Chardan Capital Reiterates Buy on Gain Therap...
Benzinga Newsdesk
Tuesday, March 26, 2024
Gain Therapeutics Q4 EPS $(0.29) Beats $(0.32) Estimate
Happy Mohamed
Gain Therapeutics: Q4 Earnings Insights
Benzinga Insights
Gain Therapeutics FY23 EPS $(1.71) Vs $(1.48)...
Benzinga Newsdesk
Tuesday, March 05, 2024
Market-Moving News for March 5th
Benzinga Newsdesk
EXCLUSIVE: Gain Therapeutics Highlights Lead Program Data Showcasing Its Impact On Cellular Death For Treating Parkinson's Disease
Vandana Singh
EXCLUSIVE: Gain Therapeutics Tells Benzinga '...
Benzinga Newsdesk
EXCLUSIVE: Gain Therapeutics Tells Benzinga C...
Benzinga Newsdesk
Tuesday, February 27, 2024
Gain Therapeutics Initiates Multiple Ascendi...
Benzinga Newsdesk
Tuesday, February 06, 2024
Gain Therapeutics Announces Preclinical Data ...
Benzinga Newsdesk
Wednesday, January 31, 2024
Gain Therapeutics' CEO Matthias Alder Issues ...
Benzinga Newsdesk
Tuesday, January 16, 2024
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga Insights
Monday, December 04, 2023
HC Wainwright & Co. Maintains Buy on Gain The...
Benzinga Newsdesk
Friday, December 01, 2023
Gain Therapeutics Announces Preclinical Data ...
Benzinga Newsdesk
Tuesday, November 21, 2023
Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Lisa Levin
Gain Therapeutics shares are trading lower af...
Benzinga Newsdesk
Gain Therapeutics Announces Pricing Of $9.4M ...
Benzinga Newsdesk
Monday, November 20, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Gain Therapeutics Announces Proposed Public O...
Benzinga Newsdesk
Wednesday, October 04, 2023
Gain Therapeutics Has Dosed The First Two Sub...
Benzinga Newsdesk
Monday, September 18, 2023
HC Wainwright & Co. Reiterates Buy on Gain Th...
Benzinga Newsdesk
Tuesday, September 12, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 12, 2023
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch